Massachusetts Prostate Cancer Coalition's 2017 - Mass.gov

Massachusetts Prostate Cancer Coalition's 2017 - Mass.gov

2017 Award Recipients Charles Austin Award for Outstanding Service in Prostate Cancer Awareness Jack Colbert Memorial Award Beth Israel Deaconess M...

9MB Sizes 0 Downloads 0 Views

Recommend Documents

Prostate Cancer 2017: The Coming Sea-Change of Prostate Cancer
Aug 17, 2017 - Prostate Cancer 2017: The Coming Sea-Change of Prostate Cancer Care | Simms/Mann-UCLA Center for Integrat

Bone + Prostate Cancer - Prostate Cancer Information Group
Apr 1, 2017 - to break down bone, is an example. It is is FDA-approved to treat osteoporosis. RANKL is also involved in

The immune landscape of prostate cancer - Prostate Cancer Foundation
Shuang G. Zhao MD1, Jonathan Lehrer2, S. Laura Chang PhD3, Rajeep Das ... Martin Sjostrom PhD4, Robert B. Den MD5, Steph

Prostate Cancer Screening - CodeMap
used by physicians to detect prostate cancer are the screening Prostate Specific Antigen (PSA) blood test and the screen

Side Effects of Treatment Prostate Cancer The - Prostate Cancer UK
•Horlicks. •Fizzy drinks. •Alcohol. •High energy drinks e.g. Redbull,. •Any drinks containing guarana. •Cran

PSA Screening for Prostate Cancer Prostate Cancer - Mercy Medical
PSA Screening for Prostate Cancer. Arvind Vemula, M.D. Prostate Cancer. ○. Most common cancer in men living in the Uni

Advanced prostate cancer - Cancer Council Australia
For the first time consumers now have a reliable source of information, ..... structure of the prostate by breaking out

Nutrition & Prostate Cancer - Cancer Supportive Care
www.informedeating.org. Consumer Lab - Evaluates quality of over-the-counter supplements http://www.consumerlab.com. Doc

Testing for Prostate Cancer - American Cancer Society
Prostate cancer testing. A PSA blood test and rectal exam can tell your doctor about your prostate. Your doctor might do

AccelerAting Discovery - Prostate Cancer Foundation
Lawrence J. and Joyce Stupski. Tarnopol Family Foundation .... Laurence and Karen Mandelbaum. Bernard Marcus ... Henry a

2017 Award Recipients

Charles Austin Award for Outstanding Service in Prostate Cancer Awareness

Jack Colbert Memorial Award

Beth Israel Deaconess Medical Center Brigham and Women's Hospital Dana-Farber Cancer Institute David Godkin Garth and Lindsay Greimann Massachusetts Prostate Cancer Coalition Allen L. Snyder III

EDUCATIONAL GRANTS AdMeTech Foundation Cancer Research Foundation / ZERO Million Dollar Roundtable (MDRT) Foundation

7:30AM Registration and Breakfast

Symposium Schedule

8:00 Panel on Prevention and Screening Prostate cancer is one of the few cancers that we know how to detect early (via PSAtesting) and prevent (with drugs like finasteride). Yet it is far from clear that doing so does more good than harm: PSAtesting has led to massive over diagnosis and overtreatment, and prevention has not become widespread due to concerns that finasteride lowers the risk of indolent, but not aggressive, disease. The panel will focus on how to ensure that we practice medicine in such a way to maximize benefits and minimize harms of prostate cancer screening and prevention. Peter C. Albertsen, MD, J. Jacques Carter, MD, Marc B. Garnick, MD, Andrew Vickers, Ph.D., moderator 9:45 Panel on Active Surveillance and Early Stage Disease Active surveillance has become widely utilized for low-risk prostate cancer and has evolved significantly over the last two decades. However, many important questions and controversies remain. Can we define the molecular events that signal "progression" of low-grade disease? How to optimally identify the "wolves in sheep's dothinq'Le., those men who benefit from early treatment? How best to integrate MRI and biomarkers into treatment decision making? Which intermediate risk patients are candidates for surveillance? What interventions (diet, exercise, micronutrients, pharmacologic agents) are warranted to reduce the risk of biological progression? What is the most efficient and cost-effective way to follow patients longitudinally? Is serial biopsy still required, and in whom? Clair J. Beard, MD, Adam S. Kibei, MD, Eric A. Klein, MD, laurence Klotz, MD, moderator; Clare M. Tempany, MD

2013 KEYNOTE

Peter (. Albertsen, MD is professor of surgery and division chief, program director at the University of Connecticut Health Center in Farmington, CT.He is a trustee of the American Board of Urology. Clair J. Beard, MD is associate professor of

radiation oncology at Harvard Medical School and vice chair of genitourinary radiation oncology at Dana-Farber Cancer Institute. She is on staff at Brigham and Women's Hospital. J. Jacques Carter, MD, MPH is on the staff of

the Beth Israel Deaconess Medical Center and the medical director of the Prostate Cancer Screening and Education Program at the Dana-Farber Cancer Institute. He is the 2015 recipient of the Jack Colbert Memorial Award. 2012 KEYNOTE

Marc B. Garnick, MD is on staff at Beth Israel

Deaconess Medical Center and the Gorman Brothers Professor of Medicine at Harvard Medical School. He is the 2017 recipient of the Jack Colbert Memorial Award.

11:00 Break Adam S. Kibei, MD is chief of Urologic Surgery at

11 :15 Presentation of Austin and Colbert Awards Charles Austin Award presented to Fran and Stan Klein. Jack Colbert Memorial Award presented to Marc Garnick, MD.

Brigham and Women's Hospital and Disease Center Leader (Urology) at Dana-Farber Cancer Institute. He is also a professor of surgery at Harvard Medical School.

11 :30 Panel on Metastatic Disease and Research Metastatic prostate cancer is the second-leading cause of cancer-related death among men in the United States, responsible for more than 25,000 deaths per year. While the disease remains incurable, meaningful strides have been made recently in its treatment and in understanding of prostate cancer biology. One important revelation is the importance of androgen signaling even after the disease proves refractory to first-line hormonal therapy. This has led to development of effective new agents that form the backbone of modern treatment. Further discoveries in the areas of radiopharmaceuticals, immunotherapy and targeted therapy based on tumor genetics are broadening the prostate cancer armamentarium. The panel will focus on the latest developments in management of advanced prostate cancer. William G. Nelson, MD, Susan F. Siovin, MD, Mary-Ellen Taplin, MD, moderator

1 :OOPM Closing

2012 KEYNOTE

Eric A. Klein, MD is chairman of the Glickman

Urological and Kidney Institute at the Cleveland Clinic. He is an international leader in the biology and management of prostate cancer.

Panelists subject to change.

The Massachusetts

Prostate Cancer Coalition

(MPCC) educates, connects, and supports men-at-risk, newly diagnosed individuals, survivors, and their families. It also connects organizations and professionals in Massachusetts that seek to conquer and cure prostate cancer.

Symposium Presenters 2007 KEYNOTE

Laurence Klotz, MD is past chief of urology at Sunnybrook Health Sciences Centre and a professor of surgery at the University ofToronto. He is chairman of the World Urological Oncology Federation and the associate editor of the Journal of Urology, responsible for prostate cancer. 2006 KEYNOTE

William G. Nelson, MD, Ph.D. is the Marion I. Knott Director and professor of oncology and director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is the co-discoverer of the most common genome alteration in prostate cancer. 2008 KEYNOTE

Susan F. Siovin, MD, Ph.D. is a medical oncologist at Memorial Sloan Kettering Cancer Center, specializing in bladder and prostate cancer.

20th Anniversary Massachusetts Prostate Cancer Symposium PLEASE REGISTER BY MAY 1, 2017 MAILyour completed registration form to: MPCC,c/o Green Associates, 200 Lincoln St., #201, Boston, MA02111 FAX:617.482.3049 ONLINEATwww.masspcc.org For more information, call617 .482.3044 x28 or email [email protected]

REGISTRATION INFORMATION Name

Organization,ifapplicable

Address

City/State/Zip

Phone

Email

Mary-Ellen Taplin, MD is chair of the Executive Committee for Clinical Research, director of Clinical Research, Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute and an associate professor of medicine at Harvard Medical School. Claire M. Tempany, MD is professor of radiology at Harvard Medical School and Ferenc Jolesz Chair of Research, Radiology at Brigham and Women's Hospital. Her major areas of research interest are MR imaging of the pelvis (specifically prostate cancer) and image-guided therapy. 2016 KEYNOTE

Andrew Vickers, Ph.D. is attending research methodologist at Memorial Sloan Kettering Cancer Center. His research falls into three broad areas: randomized trials, surgical outcomes research, and molecular marker studies. A particular focus of his work is the detection and initial treatment of prostate cancer.

Email

Spouse/Companion(Name,ifattending)

DYes, I/we want to attend the 20th Anniversary Massachusetts Prostate Cancer Symposium on Friday, May 12, 2017 at the Boston Marriott Copley Place. There is no fee for the Symposium or breakfast, but attendees are invited to make voluntary contributions of $25 to partially underwrite the symposium costs.

CONTRIBUTIONS

o $25 for breakfast (optional) o $60 (includes one-year membership o$ Other amount TOTAL $

in MPCC)

_

o ENCLOSED IS MY CHECK: (Checks should be made payable to MPCCand mailed to the address above.)

o PLEASE CHARGE MY:

0 MC 0 VISA0 AMERICANEXPRESS

Exp.Date

Card #

CSC

Print Name on Card

Signature

Gifts to the Massachusetts Prostate Cancer Coalition, a 501 (c)(3) public charity, may be tax deductible to the extent allowed by law. (MPCCTax10: 04-6946891)

Massachusetts Prostate Cancer Coalition EDUCATE

I INFORM I ADVOCATE

c/o Green Associates 200 Lincoln St., #201 Boston, MA 02111

[email protected]

assachusetts Prostate Cancer Coalition 2017 ANNIVERSARY SYMPOSIUM

Leading prostate cancer specialists provide up-to-date information on the latest in prostate cancer diagnosis, treatment and research - in user-friendly language!

20TH ANNIVERSARY MASSACHUSETTS PROSTATE CANCER SYMPOSIUM Friday, May 12, 2017 7:30 AM - 1:00 PM Boston Marriott Copley Place Boston, Massachusetts

[email protected]

assachusetts Prostate Cancer Coalition 2017 ANNIVERSARY SYMPOSIUM

Tania Barber, Caring Health Center Anita Christie, Massachusetts Department of Public Health Juan Cofield, New England Area Conference, NAACP Antonio Delesline, MOCHA Thomas Farrington, Prostate Health Education Network, Inc. (PHEN) Rep. Russell Holmes, Commonwealth of Massachusetts Philip Kantoff, MD, Memorial Sloan Kettering Cancer Center Toni McGuire, Edward M. Kennedy Community Health Center Myechia Minter-Jordan, MD, Dimock Street Community Health Center Bill Rodgers, Four-time winner of the Boston Marathon William Shipley, MD, Massachusetts General Hospital Faina Shtern, MD, AdMeTech Foundation Frederica Williams, Whittier Street Community Health Center